Studies on a new paste preparation of phenylbutazone

Publisher Website
Google Scholar
Abstract
The absorption characteristics of a new paste preparation of phenylbutazone were studied in ponies and thoroughbreds. The results suggested that at a similar dose rate of 5 mg/kg greater bioavailability results from the paste than from a powder preparation. Delivery of an accurate dosage of the paste was not possible using the multidose applicator. Repeated administration of the paste preparation (5 mg/kg twice daily) indicated that it is more toxic to both ponies and thoroughbreds than a powder preparation. In addition to the toxic manifestations previously reported, a neutropenia developed during administration. Repeated intravenous administration of phenylbutazone (3.3 mg/kg twice daily) for eight days produced no adverse effects.

This publication has 0 references indexed in Scilit: